Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer

European Journal of Cancer

Volumn 46, Issue 4, 2010, Pages 826-835

  Magnusson, Cecilia ^a   Mezhybovska, Maryna ^a   Lörinc, Ester ^b   Fernebro, Eva ^c   Nilbert, Mef ^c,d   Sjölander, Anita ^a  

^a Cell and Experimental Pathology   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Catenin; Colorectal cancer; CysLT1R; CysLT2R

Indexed keywords

BETA CATENIN; CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSTEINYL LEUKOTRIENE RECEPTOR 2; LEUKOTRIENE RECEPTOR; PROTEIN BCL X; UNCLASSIFIED DRUG; CTNNB1 PROTEIN, HUMAN; LEUKOTRIENE D4 RECEPTOR; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL NUCLEUS; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; CELL DIFFERENTIATION; CLINICAL TRIAL; COLORECTAL TUMOR; CYTOSOL; EPIDEMIOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CELL DIFFERENTIATION; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOSOL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECEPTORS, LEUKOTRIENE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 76049111365     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.12.022     Document Type: Article

References (36)

1. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 6917 (2002) 860-867
2. Ekbom A., Helmick C., Zack M., and Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. New Engl J Med 323 18 (1990) 1228-1233
3. Massoumi R., and Sjölander A. The role of leukotriene receptor signaling in inflammation and cancer. ScientificWorldJournal 7 (2007) 1413-1421
4. Dubois R.N., Abramson S.B., Crofford L., et al. Cyclooxygenase in biology and disease. FASEB J 12 12 (1998) 1063-1073
5. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220 (1983) 568-575
6. Sala A., Zarini S., and Bolla M. Leukotrienes: lipid bioeffectors of inflammatory reactions. Biochemistry 63 1 (1998) 84-92
7. Thun M.J., Calle E.E., Namboodiri M.M., et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 84 19 (1992) 1491-1500
8. Wang D., and DuBois R.N. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett 267 2 (2008) 197-203
9. Wikström K., Öhd J.F., and Sjölander A. Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2. Biochem Biophys Res Commun 302 2 (2003) 330-335
10. Lynch K.R., O'Neill G.P., Liu Q., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 6738 (1999) 789-793
11. Heise C.E., O'Dowd B.F., Figueroa D.J., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 39 (2000) 30531-30536
12. Ciana P., Fumagalli M., Trincavelli M.L., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. Embo J 25 19 (2006) 4615-4627
13. Dahlen S.E., Haeggstrom J.Z., Samuelsson B., Rabe K.F., and Leff A.R. Leukotrienes as targets for treatment of asthma and other diseases. Current basic and clinical research. Am J Respir Crit Care Med 161 2 Pt 2 (2000) S1
14. 4 activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 115 (2002) 1883-1893
15. 1 receptor signalling in intestinal epithelial cells. Oncogene 25 50 (2006) 6660-6665
16. 4 involves the prevention of caspase 8 activation and Bid cleavage. Biochem J 371 1 (2003) 115-124
17. 4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J Biol Chem 281 10 (2006) 6776-6784
18. 4 mediates survival and proliferation via separate but parallel pathways in the human intestinal Epithelial cell line Int 407. J Biol Chem 278 46 (2003) 45577-45585
19. 4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J Biol Chem 280 14 (2005) 13538-13544
20. Magnusson C., Ehrnström R., Olsen J., and Sjölander A. An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation. Cancer Res 67 19 (2007) 9190-9198
21. Conacci-Sorrell M., Zhurinsky J., and Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109 8 (2002) 987-991
22. Korinek V., Barker N., Morin P.J., et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275 5307 (1997) 1784-1787
23. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 127 3 (2006) 469-480
24. Fernebro E., Bendahl P.O., and Dictor M. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations. Int J Cancer 111 6 (2004) 921-928
25. 1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 124 1 (2003) 57-70
26. Dukes C.E. The classification of cancer of the rectum. J Pathol Bacteriol 35 (1932) 323-332
27. Kumar A., and Fausto Mitchell. Robbins basic pathology. 8th ed. (2007), W.B. Saunders, Philadelphia
28. Hamilton S.R., Rubio C.A., Vogelstein B., et al. Carcinoma of the colon and rectum (2000), IARC Press, Lyon p. 101-19
29. 1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65 3 (2005) 732-742
30. Humphries A., and Wright N.A. Colonic crypt organization and tumorigenesis. Nat Rev Cancer 8 6 (2008) 415-424
31. Ysebaert L., Chicanne G., Demur C., et al. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 20 7 (2006) 1211-1216
32. Steele V.E., Hawk E.T., Viner J.L., and Lubet R.A. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. Mutat Res 523-524 (2003) 137-144
33. Steele V.E., Holmes C.A., Hawk E.T., et al. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomark Prev 8 5 (1999) 467-483
34. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 5 (1998) 705-716
35. Melstrom L.G., Bentrem D.J., Salabat M.R., et al. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res 14 20 (2008) 6525-6530
36. Öhd J.F., Wikström K., and Sjölander A. Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 119 4 (2000) 1007-1018